Atherogenic dyslipidemia is a critical factor in developing CVD related to Metabolic Syndrome. While atherogenic dyslipidemia plays a prominent role in the development of atherosclerosis, endothelial dysfunction works alongside atherogenic dyslipidemia to contribute to the development of CVD as endothelial dysfunction also promotes atherosclerotic plaque development. This effect may provide to be synergistic in patients with MS, as endothelial dysfunction is predominantly found in this population. Other modes of action exist in MS which directly influence atherogenic dyslipidemia.
The top journals are peer reviewed scholarly journals of green chemistry. These provide high quality, meticulously reviewed and rapid publication, to cater the insistent need of scientific community. These journals are indexed with all their citations noted. The top open access journals are indexed in SCOPUS, COPERNICUS, CAS, EBSCO and ISI.
Last date updated on April, 2021